Eldoneo Capsule (Erdosteine)

Adult dose

Adults: Administer erdosteine 300mg orally 2~3 times daily. When administered for acute respiratory diseases, do not use continuously for more than 10 days.

This medication should not be used by individuals allergic to this drug or any of its components. Patients with liver cirrhosis or certain metabolic disorders such as cystathionine synthetase deficiency should not use this medication as it may affect methionine metabolism. Patients with peptic ulcers should also avoid taking this medication. Patients with severe renal impairment, particularly those with a creatinine clearance less than 25 mL/min, should not use this medication. Patients with severe liver dysfunction should also avoid taking this medication. For patients with mild to moderate liver dysfunction, care should be taken when administering this medication, ensuring the daily dosage does not exceed 300 mg. Overdosing this medication may result in symptoms such as excessive sweating, dizziness, or facial flushing. Neurological and respiratory side effects such as headaches, cold symptoms, and difficulty in breathing may occur. Gastrointestinal symptoms such as taste disturbance, nausea, vomiting, diarrhea, abdominal pain, and heartburn may also be reported. Skin symptoms such as hives, reddening of the skin, and eczema may occur. In post-marketing surveys, various adverse reactions such as fatigue, dyspepsia, palpitations, edema, itching, weakness, drowsiness, and rash have been reported, but a direct relation with this medication is unclear. Care should be taken when using this medication alongside expectorants, as such combination may lead to increased bronchial congestion, complicating the expulsion of phlegm, which may raise the risk of bronchial infections or cause bronchospasm. Animal studies have not shown any specific harmful effects during pregnancy or fetal development; however, it is advisable not to administer this medication to pregnant or potentially pregnant women, as well as nursing women, since its safety has not been sufficiently established. This medication should be stored out of the reach of children and care should be taken when transferring to other containers, as it may cause accidents or degrade the quality of the medication.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

Consult with a doctor or pharmacist if taking this medication in conjunction with cough medications.

This medication must be stored in a tightly sealed container to protect it from air and moisture exposure. It is important to maintain the storage temperature between 1 and 30 degrees Celsius. This helps to preserve the medication's effectiveness for a longer period.

Appearance

Hard capsule with a green top and yellow bottom containing white powder

Package unit

PTP packaging - 10 capsules/box [10 capsules/PTP], bottle packaging - 30 capsules/bottle, bottle packaging - 300 capsules/bottle